Faeth Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FTH)

CUSIP: 81728A207

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 6 signals
Share change
+53,405
SEC-reported price per share
$8.58
Number of holders
10
Value change
+$593,398
Number of buys
9
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
25,766,750

Security key

81728A207

Report period

Q2 2025

Institutions

10

Top holders

10

Ownership snapshot

Top reported holders of FTH - Faeth Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Mar 2025
13F 3/4/5 Highest disclosed value: $230,717 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $230.7K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $230.7K
Ikarian Capital, LLC $177.3K
Catalio Capital Management, LP $116K
Robert Hamilton Pierce $80.3K
RENAISSANCE TECHNOLOGIES LLC $69.9K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$230,717
585,576 shares
— 31 Mar 2025
Ikarian Capital, LLC
13F
Company
13F
—
denominator unverified
$177,285
449,963 shares
— 31 Mar 2025
Catalio Capital Management, LP
13F
Company
13F
—
denominator unverified
$115,983
294,374 shares
— 31 Mar 2025
Robert Hamilton Pierce
3/4/5
Chief R&D Officer
—
denominator unverified
$80,294
94,463 shares
— 15 Feb 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$69,856
177,300 shares
— 31 Mar 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$59,393
150,709 shares
— 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
10
Shares
69,928
Rows available
10
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q2 2026 Across Filers

Q2 2026 holders
44
Q2 2025 holders
10
Holder diff
-34
Investor Q2 2026 Shares Q2 2025 Shares Share Diff Share Chg % Q2 2026 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .